stressreducer | ||||
| ||||
|
stress test, Stress relief, sunburn treatment, stress reducer, stress reducers, stress release, stress releif, stress reliever, stress relievers, stress relieving technique, stress relieving techniques, stress reduction, stress support, substance abuse treatment, super b complex, super detox program, super green tea extract, super hca, super nutrition antioxidant, sub adrene All of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the placebo controls reported either no change or a worsening of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion and runny nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged the safety of the treatment. The panel seemed to be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge stressreducer testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four of the stressreducer five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6 All of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to 70%, while the placebo controls reported either no change or a worsening of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion and runny nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged the safety of the treatment. The panel seemed to be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge stressreducer testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four of the stressreducer five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6 ©2003 www.specified-ailments-treatments.com. All rights reserved. |